IP Library › Granted Patent US 11,185,574
Granted Patent B2
US 11,185,574 · App. 16/877,703 · Granted Nov 30, 2021

Protective solution for preventing or reducing reperfusion injury of the brain and the whole body

Inventors: Christoph Benk (Freiburg, DE); Friedhelm Beyersdorf (Freiburg, DE); Georg Trummer (Freiburg, DE)
Assignee: ResuSciTec GmbH
A61K38/385
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,574
App. No.
16/877,703
Granted
Nov 30, 2021
Kind
B2
Abstract

The present invention relates to a protective solution for preventing or reducing reperfusion injury of the brain which contains magnesium ions and which has an osmolality of 350 to 600 mOsm/L, a pH value of 6.8 to 7.8 and albumin in an amount of 1 to 20% by weight.

Claims (19)

1. A protective solution for reducing reperfusion injury of the brain comprising magnesium ions, sugar alcohol in an amount of 1-65 g/l, and albumin in an amount of 1 to 20% by weight, wherein said protective solution has an osmolality of 460 to 650 mOsm/L and a pH value of 6.8 to 7.3.

2. The protective solution according to claim 1 , characterized in that it contains a sugar alcohol in an amount of 1-50 g/l.

3. The protective solution according to claim 2 , characterized in that the sugar alcohol is mannitol.

4. The protective solution according to claim 1 , characterized in that the sugar alcohol is mannitol.

5. The protective solution according to claim 1 , characterized in that it contains 5,000 to 50,000 IU heparin per liter of solution.

6. The protective solution according to claim 5 , characterized in that it contains 10,000 to 50,000 IU heparin per liter of solution.

7. The protective solution according to claim 1 , characterized in that the albumin is human serum albumin.

8. The protective solution according to claim 1 , characterized in that it contains lidocaine in an amount of 0.05-1 g per 1 of solution.

9. The protective solution according to claim 1 , characterized in that the magnesium is present in a concentration of 0.1 to 15 mmol/l.

10. The protective solution according to claim 1 , characterized in that it contains citrate ions in a concentration of 20 to 100 mmol/l solution.

11. The protective solution according to claim 1 , characterized in that it contains Cyclosporin in an amount of 50 mg to 1300 mg per liter of protective solution.

12. The protective solution according to claim 1 , wherein the solution comprises less than 0.5 mmol/l calcium ions.

13. The protective solution according to claim 1 , characterized in that it contains albumin in an amount of 5 to 10% by weight.

14. A method for reducing reperfusion injury of the brain after cardiopulmonary resuscitation comprising administering a protective solution comprising magnesium ions, sugar alcohol in an amount of 1-65 g/l, and albumin in an amount of 1 to 20% by weight, wherein said protective solution has an osmolality of 460 to 650 mOsm/L and a pH value of 6.8 to 7.3.

15. The method of claim 14 , wherein said protective solution further contains 0.1-25.0 mmol potassium per liter of solution.

16. The method of claim 14 , wherein said protective solution contains a sugar alcohol in an amount of 1-50 g/l.

17. The method of claim 16 , wherein said sugar alcohol is mannitol.

18. The method of claim 14 , wherein said sugar alcohol is mannitol.

19. The method of claim 14 , wherein said protective solution contains 5,000 to 50,000 IU heparin per liter of solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2020
From: BENK, CHRISTOPH; BEYERSDORF, FRIEDHELM; TRUMMER, GEORG
To: RESUSCITEC GMBH
Reel/Frame 052698/0254 →
Priority Claims (1)
EP 13175243 · Jul 5, 2013 · regional
Continuity (2)
Continuation 14902196
Related Publication 20200276277A1 · Sep 3, 2020
Cited By (1)
US 12,419,763